Future of Novo Nordisk, Lundbeck and Ascendis Pharma trials in Ukraine remains unclear

Ukraine is home to many clinical trials being run by big Danish pharmaceutical companies, but it’s too early to tell whether development time lines will be impacted by the war.
People leaving Ukraine as Russia begins invasion | Photo: UMIT BEKTAS/REUTERS / X90076
People leaving Ukraine as Russia begins invasion | Photo: UMIT BEKTAS/REUTERS / X90076
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

As Russia continues its attempts to take over Kyiv, pharmaceutical companies take stock of how the war might impact drug development plans.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading